Type 2 Diabetes Clinical Trial
Official title:
The Influence of Overfeeding Different Macronutrients on Whole-body Insulin Sensitivity
NCT number | NCT03863431 |
Other study ID # | R18-P222 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | May 22, 2019 |
Est. completion date | June 2021 |
This study will investigate the effect of high-carbohydrate vs. high-fat overfeeding (130% of energy requirements) on whole body insulin sensitivity. Following habitual diet, participants will be randomly allocated to either a high-carbohydrate or a high-fat diet intervention for 14-days. On days 0, 7 and 14 participants will undergo anthropometric and metabolic testing (primarily an oral glucose tolerance test [OGTT]).
Status | Recruiting |
Enrollment | 20 |
Est. completion date | June 2021 |
Est. primary completion date | June 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 40 Years |
Eligibility | Inclusion Criteria: - 18-40 years - BMI = 18.5-29.9 kg/m2 - Male or female - Physically active (> 3 x 30 min moderate exercise per week) - Non-smoker (including the use of vaporisers and e-cigarettes) - Healthy (determined by the School's standard health questionnaire) - No cardiometabolic or inflammatory illness Exclusion Criteria: - Outside of age-range - Outside BMI range - Inactive (< 3 x 30 min moderate exercise per week) - Smoker - Taking medication - History of cardiometabolic or inflammatory illness - Vegetarian/ vegan (as the high-fat diet is based on animal fats) - Other dietary restrictions which prevent consumption of the experimental diet - Consumption of probiotics within last 3 months (these influence the gut microbiota) - Participation in another clinical trial - Those with known or suspected food intolerances, allergies or hypersensitivity - Women who are known to be pregnant or who are intending to become pregnant over the course of the study |
Country | Name | City | State |
---|---|---|---|
United Kingdom | School of Sport, Exercise and Health Sciences | Loughborough | Leicestershire |
Lead Sponsor | Collaborator |
---|---|
Loughborough University |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Whole-body insulin sensitivity index | Assessed by oral glucose tolerance test | The change between pre-, during and post- dietary interventions: Assessed on days 0, 7 and 14 | |
Secondary | Body Mass Index | Calculated from height and weight | Day 0, Day 7, Day 14 | |
Secondary | Fasting plasma glucose concentration | Measured in fasting plasma sample by spectrophotometric assay | Day 0, Day 7, Day 14 | |
Secondary | Fasting serum insulin concentration | Measured in fasting serum sample by ELISA | Day 0, Day 7, Day 14 | |
Secondary | Fasting plasma lipid profile (for example total and HDL cholesterol and TAG concentrations; all measured in mmol/L) | Measured in fasting plasma sample by spectrophotometric assay | Day 0, Day 7, Day 14 | |
Secondary | Indirect calorimetry | Measured from expired gas samples | Day 0, Day 7, Day 14 | |
Secondary | Subjective appetite ratings | Measured from visual analogue scale appetite questionnaires | Day 0, Day 7, Day 14 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05219994 -
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
|
N/A | |
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Completed |
NCT02284893 -
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
|
Phase 3 | |
Completed |
NCT04274660 -
Evaluation of Diabetes and WELLbeing Programme
|
N/A | |
Active, not recruiting |
NCT05887817 -
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
|
Phase 4 | |
Active, not recruiting |
NCT05566847 -
Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Completed |
NCT04965506 -
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
|
Phase 2 | |
Recruiting |
NCT06115265 -
Ketogenic Diet and Diabetes Demonstration Project
|
N/A | |
Active, not recruiting |
NCT03982381 -
SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes
|
Phase 4 | |
Completed |
NCT04971317 -
The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages
|
N/A | |
Completed |
NCT04496154 -
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
|
N/A | |
Completed |
NCT04023539 -
Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
Completed |
NCT04097600 -
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
|
Phase 1 | |
Completed |
NCT05378282 -
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
|
||
Active, not recruiting |
NCT06010004 -
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT03653091 -
Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes
|
N/A |